Mood Disorder Research Program
Patient-Centered Customized Psychosocial Adherence Enhancement Intervention Schizophrenia (CAE-S) Study
Prospective 12-week randomized controlled trial (RCT) of remotely- delivered Customized Adherence Enhancement for poorly adherent individuals with schizophrenia (CAE-S) vs Enhanced Treatment as Usual (eTAU)
Age: 18+ years
Sex at Birth: All
Sex at Birth: All
Type: Interventional study
Condition: Schizophrenia
Condition: Schizophrenia
Healthy Participants: No
Location: UH Cleveland Medical Center
Location: UH Cleveland Medical Center
Learn More About This Research Study
To learn more about this study please complete the online form below.
Study Purpose
The purpose of the study is to see if a behavioral intervention helps people who have schizophrenia take their medication more consistently and better manage their symptoms. Participating is the study lasts about 3 months and includes 3 study visits and 6 educational session visits. All visits can be done via video conferencing and compensation is provided.
Who Can Participate
Participants 18 years or older diagnosed with schizophrenia may be eligible for this study.
- STUDYID 2022-01101